Advertisement
AD

Main navigation

Advertisement

ETH and XRP Price Analysis for November 21

Advertisement
Mon, 21/11/2022 - 15:16
ETH and XRP Price Analysis for November 21
Cover image via www.tradingview.com

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Read U.TODAY on
Google News

The situation is almost unchanged since yesterday as the majority of the coins keep trading in the red zone.

Advertisement

Top 10 coins by CoinMarketCap

ETH/USD

The rate of Ethereum (ETH) has declined by 4.32% over the last day.

ETH/USD chart by TradingView

The rate of Ethereum (ETH) has continued yesterday's drop, getting closer to the support level of $1,071. If buyers lose the important $1,100 zone, the accumulated power might be enough for a fall to the $1,000 area.

The following scenario is relevant until the end of the week.

Ethereum is trading at $1,122 at press time.

XRP/USD

XRP is more of a loser than Ethereum (ETH), going down by 7%.

XRP/USD chart by TradingView

Despite today's sharp fall, XRP is trading in the middle of the wide channel, far away from the key levels. However, the selling volume is high, which means that a further drop is more likely than a bounce back. In this case, the next area at which bulls may seize the initiative is the area of $0.32.

XRP is trading at $0.3511 at press time.

A
A
A

Related articles

Advertisement
TopCryptoNewsinYourMailbox
TopCryptoNewsinYourMailbox
Advertisement
Advertisement

Recommended articles

Latest Press Releases

Our social media
There's a lot to see there, too

Popular articles

Advertisement
AD